top stonk selection for permabulls hello all time for some light fun :d stonks only go up- this one must have 200x upside! welcome to the infinite liquidity basket :Dby gggambles2
INDPIndaptus Therapeutics Inc (NASDAQ:INDP) Over 25% of INDP's tradable shares are in the hands of short sellers, meaning they sold the stock and are holding for further declines. Unlike buying a stock, when you can only lose as much as you invest, a short seller's loss potential is unlimited, which is one of the reasons why short squeezes occur, specifically in stocks like INDP with a thin public float. Chief Executive Officer, will participate in a pre-recorded presentation at the H.C. Wainwright BioConnect 2022 Virtual Conference made available on Monday, so stay tuned. The stock has built a nice base, which suggests the shares could keep moving significantly higher in the coming months. Definitely on watch next week.Longby SmoothJB1
INDPIndaptus Therapeutics, Inc. (INDP) is setting up for a possible breakout, which based on the chart could send the stock up like a rocket. The RSI14 at 40 and the MACD is still curling upward. Chart on Breakout Watch.Longby SmoothJB1
mid term +700%Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy. by SPIRITUAL7INTERELLECTUAL2
INDPIndaptus Therapeutics Inc (NASDAQ:INDP) The company's 13D filing on Friday after hours showed that Michael J. Newman had reported a stake of 25.7% in the company. The filing came out later in the session, so I think the stock should see a nice bump when it opens for trade on Monday. With such a low float and an oversold chart, this could create an explosive situation. If INDP is not on your watchlist now is the time to add it.Longby SmoothJB111